Medx Health Corp V.MDX

Proper Research on MedX

[Insightful1]

I think Bob McWhirter was an early stage investor in MedX back at the .$10 range, he annonced he only held warrants ( One of his BNN interviews) which means when the stock got ahead of itself back in 2018 he must have sold his position. 

The most knowledgable analyst that follows MedX is Doug Cooper at Beacon Securities. Doug always updates his coverage when MedX makes a material announcement. MedX has Institutional Investors now who trust Doug's guidance and that would explain the volume and higher prices. Note in the latest report MedX is still deeply undervalued on a comparative basis.

Here is Doug's report;

https://medxhealth.com/assets/research/MDX-2020-12-15.pdf

[hopefull]

The report is pretty much what you have reported in the past. A few takeaways. the report has a target price of .45. Which would be great and I think long term we will get there. The lack of a follow up in the Netherlands with respect to the couple more machines by last years end would have indicated a really good forward momentum. ???What happened with that? a quote from the report and I am only

[Insightful1]

if you read my comments carrefully you would have noticed I wasn't commenting on the latest report from Beacon. You took this out of context, the point I was making was  Bob McWhirter has sold off his position in MedX (as he stated) and the most knowledgable analyst following MedX currently  is Doug Cooper at Beacon Securities. I included his latest report in the post. The lack of

[hopefull]

thanks for clarifying. I would be extremely happy if Medx were in the 60$ range. Then please give us your opinion on why Mdex is having such a hard time convincing the market and why you believe the share price is having difficulties moving.

[hopefull]

You aren't actually comparing Medx to DermTech are you. They have a large market cap be used they have Sales and are proven. Medx has neither and your saying that dilution has no impact. Please. Market cap really won't play so much if the share price would move and put the value of Medx way up. Long way to go still. Until sales occur nothing will matter. Prove sales first

[Insightful1]

Then I strongly recomend you sell MedX, if you own any, and buy DermTech. If the market cap doesn't matter and they are a proven technology by there huge sales it begs the question? Why would you even bother to be posting here????

[hopefull]

sorry to offend you but I bought in because I believed it would save lives. I bought in on a vision, I bought in because I believe and still do. What I'm pointing out much to your dismay as I have continually stated, Medx needs strong sales and much improved communication neither have occured. And yes I believe that on a day to day operations when they get sales or completed a goal, Medx

[Insightful1]

Trust me, I do not take it personally. I am pointing out logic flaws as I see them.I have difficulty in understanding the way you mix statements and facts.My comments were quite simple if you think a company that burns 9 million a quarter to produce 1 million in sales is worth a market cap of 1.6 billion then you should own that company. I am pointing out a logic flaw around your dilution

[hopefull]

market cap is based on share price to outstanding shares. Medx us exactly where they should be based in that calc. Help me understand your position.

[Insightful1]

It is a statement about relative value If you multiply DermTech share price by tthe number of shares outstanding you get a mkt.cap of $1.6 billion. That is what the market thinks  DermTech value is. MedX's market cap is $38 million, substantially lower. However, you can now look at the comparative financials to determine if DermTech is overvalued compared to MedX or is Medx undervalued